Multiple Sclerosis: Therapeutic Strategies on the Horizon.

Cureus · 2022 · PMC9187186 · PMID 35706718

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

It showed a trend of better efficacy with methylprednisolone (MP) and intravenous (IV) treatment but no significant difference between the short (five days) or long (15 days) duration of therapy [ 47 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.